STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Grant and other income	$ 104,170	$ 17,389	$ 350,029	$ 51,822
Operating Expenses:
Research and development	2,425,562	3,180,401	7,713,873	13,307,275
General & administrative	1,748,971	1,595,707	5,823,694	4,347,830
Total operating expenses	4,174,533	4,776,108	13,537,567	17,655,105
Operating loss	(4,070,363)	(4,758,719)	(13,187,538)	(17,603,283)
Gain (loss) on derivative instruments	(8,618)	790,365	187,967	9,669,977
Interest expense, net	(1,935,587)	(495,709)	(3,910,962)	(1,436,095)
Net loss available to common shareholders	$ (6,014,568)	$ (4,464,063)	$ (16,910,533)	$ (9,369,401)
Net loss per common share
Basic	$ (.36)	$ (.53)	$ (1.17)	$ (1.29)
Diluted	(.36)	(.53)	$ (1.17)	$ (1.34)
Basic and diluted	$ (0.36)	$ (0.53)
Weighted average common shares outstanding
Basic	16,651,297	8,405,790	14,486,351	7,235,140
Diluted	16,651,297	8,405,790	14,486,351	7,292,715
Basic and diluted	16,651,297	8,405,790